Q. Years ago, I wrote to you reporting that my snoring improved while I took Vascepa. That was what my wife said, and I’d ...

DEAR PEOPLE’S PHARMACY: I took finasteride for about four months to treat BPH (benign prostate hypertrophy) and prostatitis.

A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...

Regeneron’s lead counsel was Jonathan D. Polkes of White & Case LLP.

Ten products delivered at least double-digit sales growth in the fourth quarter, including Repatha (evolocumab), Blincyto (blinatumomab), Tezspire (tezepelumab-ekko), Evenity (romosozumab-aqqg ...

CHICAGO, IL—Patients with stable CAD who respond well to the PCSK9 inhibitor evolocumab (Repatha; Amgen) have differences in gene expression compared with nonresponders, according to new data from the ...

Most Medicare Part D (prescription drug) plans cover Repatha (evolocumab). However, because private insurers provide Part D plans, coverage may vary by plan. Most commercial insurance plans and ...

Repatha (evolocumab) is a prescription drug that’s used in certain situations to decrease serious heart-related risks and lower cholesterol. Repatha comes as a liquid solution for injection ...

Credit: Amgen. The Repatha Pushtronix System will be discontinued as of June 30, 2024. Amgen has announced that the Repatha (evolocumab) Pushtronix ® System (single-dose on-body infusor with ...

The U.S. Supreme Court earlier Monday heard arguments in a patent case filed by Amgen (NASDAQ:AMGN) regarding its cholesterol lowering, PCSK9 inhibitor biologic Repatha (evolocumab). Amgen has ...

Very low LDL-C Levels <20 mg/dL Were Well Tolerated With no new Safety Signals and Were Associated With a Reduced Risk of Cardiovascular Outcomes Data Reinforces Long-Term Efficacy and Consistent ...